by CytoReason
Sometimes, the most thought-provoking conversations happen beyond the office — in the lobby of a Palo Alto hotel, a coffee shop in Cambridge Mass, or even on the stunning beaches of Crete.<br /><br />When you connect with leading experts who share your passion for pharma and biotech, business and innovation, some really powerful ideas come to life.<br /><br />Welcome to CytoSpecial, a CytoReason production.
Language
🇺🇲
Publishing Since
1/2/2025
Email Addresses
1 available
Phone Numbers
0 available
January 2, 2025
How will vast omics datasets and AI reshape drug development and personalized medicine?<br /><br />How do you disrupt pharma's systemic intertia and the industry’s cautious adoption of innovation?<br /><br />How can more access to data scale the business and drive leadership in AI-driven healthcare?<br /><br />CytoReason's CEO, David Harel, and Candesic's Managing Partner, Leonid Shapiro, come together to discuss these and other questions at the intersection of AI, data, and healthcare during CytoReason's annual CytoSummit conference.<br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.